Knowledge Distillery

The objective of this case-control study was to estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S…

The objective of this simulation agent based modeling study was to estimate population health outcomes with delayed second dose versus standard…

The objective of this population based cohort study was to assess rates of cardiovascular and haemostatic events in the first 28 days after…

After the emergence of COVID-19, studies reported a decrease in hospitalizations of patients with ischemic stroke (IS), but there are little to no…

Pregnant women are at increased risk of morbidity and mortality from COVID-19 but have been excluded from the phase 3 COVID-19 vaccine trials. Data on…

Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and serious condition, has been described in Europe following receipt of the…

In this article the authors systematically reviewed the literature on COVID-19 in patients with multiple sclerosis (MS). They searched PubMed, Scopus,…

The COVID-19 pandemic continues to affect millions of people globally, with increasing reports of neurological manifestations but limited data on…

Although COVID-19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke,…

Parkinson’s disease (PD), possibly due to associated factors. This study aimed to systematically review the factors associated with COVID-19 in people…

Central and peripheral nervous system involvement during acute COVID-19 is well known. Although many patients report some subjective symptoms months…

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, neurological symptoms increasingly moved into the focus of interest.